PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23826352-6	2013	Further analysis showed that rHDL containing the carboxyl-terminal deletion mutant apoA-I[Delta(185-243)] only slightly reduced (by 22%) the ABCG1-mediated efflux of 7-ketocholesterol, indicating that depending on the sterol type, structural changes in rHDL-associated apoA-I affect differently the ABCG1-mediated efflux of cholesterol and 7-ketocholesterol.	7-ketocholesterol	340-357	apolipoprotein A1	Homo sapiens	83-89	
10933125-6	2000	Importantly, the effects of oxysterols, such as 7-ketocholesterol (7KC), on cholesterol and other lipid efflux by apoA-I needs to be investigated in any attempt to utilise apoA-I as an agent to stimulate efflux of lipids.	7-ketocholesterol	48-65	apolipoprotein A1	Homo sapiens	114-120	
8910326-11	1996	Efflux of 7-ketocholesterol was time and concentration dependent, and the rate of its removal was 50-fold greater for hydroxypropyl-beta-cyclodextrin than for apolipoprotein A-I.	7-ketocholesterol	10-27	apolipoprotein A1	Homo sapiens	159-177	
11669638-1	2001	Cholesterol removal from lipid-loaded macrophages is an important, potentially antiatherogenic process, and we have previously shown that an oxysterol, 7-ketocholesterol (7K), can impair efflux to lipid-free apoprotein A-1 (apoA-1).	7-ketocholesterol	152-169	apolipoprotein A1	Homo sapiens	224-230	
10484610-2	1999	For example, 7-ketocholesterol (7KC) inhibits cholesterol efflux from macrophage foam cells induced by apolipoprotein A-I (apoA-I).	7-ketocholesterol	13-30	apolipoprotein A1	Homo sapiens	103-121	
10484610-2	1999	For example, 7-ketocholesterol (7KC) inhibits cholesterol efflux from macrophage foam cells induced by apolipoprotein A-I (apoA-I).	7-ketocholesterol	13-30	apolipoprotein A1	Homo sapiens	123-129	
23826352-6	2013	Further analysis showed that rHDL containing the carboxyl-terminal deletion mutant apoA-I[Delta(185-243)] only slightly reduced (by 22%) the ABCG1-mediated efflux of 7-ketocholesterol, indicating that depending on the sterol type, structural changes in rHDL-associated apoA-I affect differently the ABCG1-mediated efflux of cholesterol and 7-ketocholesterol.	7-ketocholesterol	166-183	apolipoprotein A1	Homo sapiens	83-89	
16042420-0	2005	The polar nature of 7-ketocholesterol determines its location within membrane domains and the kinetics of membrane microsolubilization by apolipoprotein A-I.	7-ketocholesterol	20-37	apolipoprotein A1	Homo sapiens	138-156	
16042420-8	2005	Compared to cholesterol, 7-ketocholesterol decreased the rate for the microsolubilization of dimyristoyl-PC multilamellar vesicles by apolipoprotein A-I.	7-ketocholesterol	25-42	apolipoprotein A1	Homo sapiens	134-152	
14734645-7	2004	Conditions that selectively deplete plasma membrane lipid raft cholesterol, such as incorporation of 7-ketocholesterol or rapid exposure to cyclodextrins, block apoA-1 binding to these domains but also inhibit cholesterol efflux from the major, slow pool.	7-ketocholesterol	101-118	apolipoprotein A1	Homo sapiens	161-167